Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Colan Totte CoTSE:7792 +0.07%90 ROC (Joel Greenblatt) % is 68.32% as of Mar. 2026, which is 9% below its 10-year median of 74.89. GuruFocus rates TSE:7792 with a GF Score™ of 90/100 and a GF Value™ of 円1,548.65 (Fairly Valued). The stock has 2 warning signs investors should review. Among 837 Medical Devices & Instruments companies, Colan Totte Co ranks better than 94.62% on this metric.
Joel Greenblatt defined Return on Capital differently in his book The Little Book That Still Beats the Market (Little Books. Big Profits). He defines ROC (Joel Greenblatt) % as EBIT divided by the total of Property, Plant and Equipment and net working capital. Colan Totte Co's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2026 was 68.32%.
The historical rank and industry rank for Colan Totte Co's ROC (Joel Greenblatt) % or its related term are showing as below:
TSE:7792'
s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: 40.88 Med: 74.89 Max: 94.6
Current: 75.55
During the past 7 years, Colan Totte Co's highest ROC (Joel Greenblatt) % was 94.60%. The lowest was 40.88%. And the median was 74.89%.
TSE:7792's ROC (Joel Greenblatt) % is ranked better than 94.62% of 837
companies
in the Medical Devices & Instruments industry
Industry Median: 4.35
vs TSE:7792: 75.55
Colan Totte Co's 5-Year average Growth Rate of ROC (Joel Greenblatt) % was 13.00% per year.
Colan Totte Co (TSE:7792) ROC (Joel Greenblatt) % Explanation
The way Joel Greenblatt defines Return on Capital is a more accurate measure of how efficiently the company generates returns onthe capital actually invested in the business. EBIT is used instead of net income because the tax and interest payment may be affected by factors other than the core business operation. Intangible assets are not included in the calculation because they don't need to be replaced.
Colan Totte Co ROC (Joel Greenblatt) % Related Terms
Colan Totte Co ROC (Joel Greenblatt) % Historical Data
* Premium members only.
The historical data trend for Colan Totte Co's ROC (Joel Greenblatt) % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TSE:7792 vs ABT, SYK, MDT: ROC (Joel Greenblatt) % Comparison
For the Medical Devices subindustry, Colan Totte Co's ROC (Joel Greenblatt) %, along with its competitors' market caps and ROC (Joel Greenblatt) % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Colan Totte Co ROC (Joel Greenblatt) % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Colan Totte Co's ROC (Joel Greenblatt) % distribution charts can be found below:
* The bar in red indicates where Colan Totte Co's ROC (Joel Greenblatt) % falls into.
Colan Totte Co ROC (Joel Greenblatt) % Calculation
Joel Greenblatt defined Return on Capital differently in his book The Little Book That Still Beats the Market (Little Books. Big Profits) . He defines Return on Capital as follows:
EBIT stands for Earnings Before Interest and Taxes.
Fixed Assets are also known as non-current assets. They include the Property, Plant and Equipment that the firm needs in its operation.
GuruFocus calculates net working capital as: (Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Deferred Revenue + Other Current Liabilities). We're trying to account for OPERATING assets and liabilities (part of daily business) when calculating working capital. Cash and marketable securities are considered NON-OPERATING assets and are not included in calculation. We will also back out all interest bearing debt, short term debt and the portion of long term debt that is due in the current period from the current liabilities. This debt will be considered when computing cost of capital and it would be inappropriate to count it twice.
Note:
The EBIT data used here is four times the quarterly (Mar. 2026) EBIT data.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a ROC (Joel Greenblatt) % of 68.32% mean?
Colan Totte Co (TSE:7792) has a ROC (Joel Greenblatt) % of 68.32% as of Mar. 2026. Joel Greenblatt's return on capital is the ratio of EBIT to average fixed assets and net working capital. View historical data on Colan Totte Co and its competitors. This is near median its historical median of 74.89. Over the past decade, Colan Totte Co's ROC (Joel Greenblatt) % has ranged from 40.88 to 94.60. According to the industry distribution chart, Colan Totte Co ranks #45 out of 837 companies in the Medical Devices & Instruments industry, placing it in the top 5.4%.
Is Colan Totte Co's ROC (Joel Greenblatt) % too high?
Colan Totte Co's current ROC (Joel Greenblatt) % of 68.32% is near median its 10-year median of 74.89. Over the past 10 years, this metric has ranged from a low of 40.88 to a high of 94.60. The Medical Devices & Instruments industry median ROC (Joel Greenblatt) % is 4.35. Colan Totte Co's value of 68.32% is 1470.6% above this industry median. Based on the distribution chart, Colan Totte Co ranks #45 out of 837 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Colan Totte Co has a GF Score™ of 90/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Colan Totte Co's ROC (Joel Greenblatt) % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Colan Totte Co ranks #45 out of 837 companies for ROC (Joel Greenblatt) %. This places Colan Totte Co in the top 5% of its industry — outperforming the majority of peers. The industry median ROC (Joel Greenblatt) % is 4.35. Colan Totte Co's value of 68.32% is 1470.6% above this benchmark. Historically, Colan Totte Co's own ROC (Joel Greenblatt) % has ranged from 40.88 to 94.60 over the past decade. While the company's 10-year median is 74.89 vs. the industry median of 4.35, Colan Totte Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROC (Joel Greenblatt) % for a Medical Devices & Instruments company?
The median ROC (Joel Greenblatt) % among Medical Devices & Instruments companies is 4.35, based on 837 companies in the industry. Companies in the top quartile (top 25%) have a ROC (Joel Greenblatt) % significantly above this median, while those in the bottom quartile fall well below. However, ROC (Joel Greenblatt) % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Colan Totte Co's current ROC (Joel Greenblatt) % of 68.32% is 1470.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROC (Joel Greenblatt) % mean?
A high ROC (Joel Greenblatt) % can signal that a stock is expensive relative to its fundamentals. Joel Greenblatt's return on capital is the ratio of EBIT to average fixed assets and net working capital. View historical data on Colan Totte Co and its competitors. For the Medical Devices & Instruments industry, the median ROC (Joel Greenblatt) % is 4.35 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Colan Totte Co's current ROC (Joel Greenblatt) % is 68.32%, which is near median its own 10-year median of 74.89. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Colan Totte Co stock overvalued right now?
Based on GuruFocus' analysis, Colan Totte Co (TSE:7792) is currently considered Fairly Valued. The stock's GF Value™ is 円1,548.65, compared to a current price of 円1,443.00 — trading 6.8% below its estimated fair value. The current ROC (Joel Greenblatt) % is 68.32%, which is near median its 10-year median of 74.89 and 1470.6% above the Medical Devices & Instruments industry median of 4.35. Colan Totte Co's overall GF Score™ is 90/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROC (Joel Greenblatt) % calculated?
ROC (Joel Greenblatt) % is calculated from a company's financial statements. For Colan Totte Co (TSE:7792), the current ROC (Joel Greenblatt) % is 68.32% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Colan Totte Co (TSE:7792) Overvalued in 2026?
Based on GuruFocus' analysis, Colan Totte Co stock appears to be undervalued.
The current stock price of 円1,443.00 is trading 6.8% below its estimated GF Value™ of 円1,548.65.
GuruFocus considers Colan Totte Co to be Fairly Valued.
Key valuation signals for TSE:7792:
ROC (Joel Greenblatt) %: 68.32% (near median its 10-year median of 74.89)
GF Value™: 円1,548.65 vs. price of 円1,443.00 (6.8% below fair value)
Industry Position: 1470.6% above the Medical Devices & Instruments median (#45 of 837)
No single metric tells the full story. See the TSE:7792 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Colan Totte Co Ltd is engaged in the manufacturing and sales of medical devices and health products. It divides its business into two segments: Colantotte Business is the brand that develops home magnetic therapy devices, which are the core of the company; and CSS Business is a service that connects people with their families, realizing contacting designated emergency contacts based on the desire to protect loved ones.
90GF Score
Get the complete analysis for TSE:7792
ROC (Joel Greenblatt) % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:7792 has been successfully added to your 
